Comparison of the Risk Malignancy Index Value of Ovarian Cancer Serosum and Musinosum Type Dr. M. Djamil Padang in 2017

Frita Dwi Luhuria(1*), Defrin Defrin(2), Andi Friadi(3)

(1) Resident of Obstetrics and Gynecology, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang
(2) Sub Division of Maternal Fetal Medicine, Obstetrics and Gynecology Department, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang
(3) Sub Division of Gynecological Oncology, Obstetrics and Gynecology Department, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang
(*) Corresponding Author

DOI: https://doi.org/10.25077/aoj.4.1.87-94.2020

Abstract


The Risk Malignancy Index (RMI) is one of the simplest assessments that can assist in diagnosing and determining the prognosis of benign and malignant adnexa masses. Epithelial carcinoma is the most common type of about 90% of ovarian cancers.  As many as 35-40% of the epithelial type are serous and 6-10% are musinosum.This study aims to compare the picture of RMI value on the incidence of ovarian cancer serosum and musinosum type. This study was cross sectinal comparative study from medical records of ovarian cancer patients at obstetrics and gynecology section in DR M Djamil Hospital Padang from January 1st, 2017 until December 31st, 2017. The population was found one hundred and forty of patients with ovarian cancer and only one hundred and twenty nine of patients met the inclusion criteria and there were no exclusion criteria. Next RMI value is calculated based on RMI 1 formula, result is described in tabular form and data processing with SPSS program. Conclucion of this study is there were no differences in age distribution, ascites occurrence and age of menopause in serous and musinosum ovarian cancer. There is a difference in Ca, 125 levels in serous with musinosum ovarian cancer which also contribute to the high value of RMI. The mean value of patients‘s RMI in serous type ovarian cancer is higher than the mean value of RMI in patients with type Musinosum ovarian cancer.

Keywords: index of risk malignancy, menopause, ultrasonography, anatomic pathology, serous ovarian carcinoma

Full Text:

PDF

References


Clarke SE, Grimshaw R, Rittenberg P, Kieser K, Bentley J. Risk of Malignancy Index in the Evaluation of Patients with Adnexal Masses. 2009.

Busmar B. Kanker Ovarium. Buku Acuan Nasional Onkologi Ginekologi. Jakarta:Yayasan Bina Pustaka Sarwono Prawirohardjo. 2006. hlm. 468-94.

Berek JS. Ovarian Cancer. Novak’s Gynecology. 13th ed. Lippincott Williams & Wilkins. 2012. hlm.1245-62.

Andrijono. Kanker Ovarium. Sinopsis Kanker Ginekologi. Fakultas Kedokteran Universitas Indonesia RS. Dr. Cipto Mangunkusumo. Jakarta :Pustaka Spirit. 2009. hlm. 167–8.

Ian J, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of Malignancy Index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer, BJOG: An International Journal of Obstetrics and Gynaecology. 2015;97(10):922-9.

Ian J, Usha M. Progress and Challenges in Screening for early Detection of Ovarian Cancer. Molecular & Cellular Proteomics. 2004. hlm. 355–66.

Mardjikoen P. Tumor Ganas Ovarium. Ilmu Kandungan. Jakarta:Yayasan Bina Pustaka Sarwono Prawirohardjo. 2005. hlm. 400-8.

FOGSI. Risk of Malignancy Index (RMI) in Evaluation of Adnexal Mass The Journal of Obstetrics and Gynecology of India (March–April 2015), 2015;65(2):117–21.

Moore R.G., Robert C. Bast JR. How Do You Distinguish a Malignant Pelvic Mass From a Benign Pelvic Mass? Imaging, Biomarkers, or None of the Above. Editorial. Journal of Clinical Oncology, Vol 25, No 27 (September 20). 2007. p. 4259 – 4161.

Mongkol B, Neungton C. Pre-operative Prediction of Serum CA 125 Level in Women with Ovarian Masses. J Med Asocc Thai;90(10): 1986-91. National Guideline Clearinghouse. 2009. Approriateness Criteria ovarian cancer screening. 2007.p. 7. Available at : www.guideline.gov. diakses tanggal 30 Juli 2018

Rasjidi I, Kusumo L, Yudasmara. Deteksi Dini Pencegahan Kanker Pada Wanita. CV Sagung Seto. Jakarta.2009. p. 193 – 195.

Salehpour S, Zhaam h, Panah T. Laparoscopic Aspiration of Ovarian Cysts. Med J Iran Hosp. 2002;4(2):422-428.

Andrade LA. Risk of Malignancy Index in preoperative evaluation of clinically restricted ovarian cancer. San Paulo Medical Journal. 2002;12(3):72-6.

Uma S, Neera K, Nisha, Ekta. Evaluation of new scoring system to differentiate between benign and malignant adnexal mass. The Journal of Obstetrics and Gynaecology of India. 2004;56(2):85 – 98.

FOGSI. Risk of Malignancy Index (RMI) in Evaluation of Adnexal Mass The Journal of Obstetrics and Gynecology of India (March–April 2015), 2015 65(2):117–121

Ian J, Usha M. Progress and Challenges in Screening for early Detection of Ovarian Cancer. Molecular & Cellular Proteomics. 2010. p. 355 – 366.

Padilla LA, Radosevich, Milad MP. Limitations of the pelvic examination for evaluation of the female pelvic organs. Internal J Gynaecol Obstet; 2008;88(1): 84-8.

Saleh A., Shorbagy MS. Preoperative Diagnosis of Ovarian Cancer in Patients Presented with Adnexal Mass using the Risk of Malignancy Index. OBGYN.net Advertisement.

Xu W, Rush J, Rickett K, Coward JIG. Mucinous ovarian cancer : A therapeutic review. Critical reviews in oncology/hematology. 206; 102:26-36.

Brown J, Frumovitz M. Mucinous tumors of the ovary : current thoughts on diagnosis and management. Curr Oncol Rep. 2014;16(6):389.


Refbacks

  • There are currently no refbacks.




Address for Correspondence:

Editorial Room Andalas Obstetrics and Gynecology Journal 3rd floor of KSM Obstetrics and Gynecology
RSUP Dr. M. Djamil Padang, Jl. Perintis Kemerdekaan Padang, Sumatara Barat, 25127